M&As in domestic pharmaceutical sector will go up

Pharmaceutical companies could benefit from mergers and acquisitions (M&As) in the changing business environment of the 21st century, according to a research institute said Wednesday.

In a conference hosted by Korea Pharmaceutical Manufacturers Association, Samjung KPMG official Park Seung-hyun said in a report that Korean companies experienced a total of 27 M&As worth of $758 million last y...